Cargando…

Individualized dynamic methylation-based analysis of cell-free DNA in postoperative monitoring of lung cancer

BACKGROUND: The feasibility of DNA methylation-based assays in detecting minimal residual disease (MRD) and postoperative monitoring remains unestablished. We aim to investigate the dynamic characteristics of cancer-related methylation signals and the feasibility of methylation-based MRD detection i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Kezhong, Kang, Guannan, Zhang, Zhihong, Lizaso, Analyn, Beck, Stephan, Lyskjær, Iben, Chervova, Olga, Li, Bingsi, Shen, Haifeng, Wang, Chenyang, Li, Bing, Zhao, Heng, Li, Xi, Yang, Fan, Kanu, Nnennaya, Wang, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10349423/ https://www.ncbi.nlm.nih.gov/pubmed/37452374 http://dx.doi.org/10.1186/s12916-023-02954-z

Ejemplares similares

Research Progress on Postoperative Minimal/Molecular Residual Disease Detection in Lung Cancer
por: Wu, Manqi, et al.
Publicado: (2022)

Monitoring of circulating tumor DNA and its aberrant methylation in the surveillance of surgical lung Cancer patients: protocol for a prospective observational study
por: Kang, Guannan, et al.
Publicado: (2019)

Potential utility of longitudinal somatic mutation and methylation profiling for predicting molecular residual disease in postoperative non‐small cell lung cancer patients
por: Li, Hang, et al.
Publicado: (2021)

Tumor mutation burden derived from small next generation sequencing targeted gene panel as an initial screening method
por: Tang, Yuan, et al.
Publicado: (2020)

Sequential ALK inhibitor treatment benefits patient with leptomeningeal metastasis harboring non‐EML4‐ALK rearrangements detected from cerebrospinal fluid: A case report
por: Li, Zhaona, et al.
Publicado: (2019)

Investigation on the potential of circulating tumor DNA methylation patterns as prognostic biomarkers for lung squamous cell carcinoma
por: Liu, Yutao, et al.
Publicado: (2020)

Targeted sequencing identifies the mutational signature of double primary and metastatic malignancies: a case report
por: Rao, Chuangzhou, et al.
Publicado: (2019)

Novel AMBRA1-ALK fusion identified by next-generation sequencing in advanced gallbladder cancer responds to crizotinib: a case report
por: Zhou, Yuling, et al.
Publicado: (2020)

Rechallenge with erlotinib in osimertinib-resistant lung adenocarcinoma mediated by driver gene loss: a case report
por: Liu, Lingli, et al.
Publicado: (2020)

Liquid‐based cell suspension of supraclavicular lymph node fine‐needle aspirate as an alternative specimen for NGS‐based genomic profiling in advanced lung cancer
por: Zhang, Xun, et al.
Publicado: (2020)

Common DNA methylation changes in biliary tract cancers identify subtypes with different immune characteristics and clinical outcomes
por: Qiu, Zhiquan, et al.
Publicado: (2022)

DNA methylation‐based profiling of bone and soft tissue tumours: a validation study of the ‘DKFZ Sarcoma Classifier’
por: Lyskjær, Iben, et al.
Publicado: (2021)

Efficacy of afatinib in a HER2 amplification-positive endometrioid adenocarcinoma patient– a case report
por: Zhou, Li, et al.
Publicado: (2019)

Effective response to crizotinib of concurrent KIF5B-MET and MET-CDR2-rearranged non-small cell lung cancer: A case report
por: Liu, Lian-Fang, et al.
Publicado: (2022)

Comparison of Next-Generation Sequencing and Ventana Immunohistochemistry in Detecting ALK Rearrangements and Predicting the Efficacy of First-Line Crizotinib in Patients with Advanced Non-Small Cell Lung Cancer
por: Zeng, Liang, et al.
Publicado: (2020)

High-level gain of mesenchymal-epithelial transition factor (MET) copy number using next-generation sequencing as a predictive biomarker for MET inhibitor efficacy
por: Wu, Shibo, et al.
Publicado: (2020)

Cell-free DNA methylation markers for differential diagnosis of hepatocellular carcinoma
por: Luo, Biyuan, et al.
Publicado: (2022)

The emergence of various genetic alterations mediated the Osimertinib resistance of a patient harboring heterozygous germline EGFR T790M: a case report
por: Liu, Bin, et al.
Publicado: (2021)

Efficacy of erlotinib as neoadjuvant regimen in EGFR-mutant locally advanced non-small cell lung cancer patients
por: Xiong, Liwen, et al.
Publicado: (2019)

Heterogeneous constitutional mismatch repair deficiency with MSH6 missense mutation clinically benefits from pembrolizumab and regorafenib combination therapy: a case report and literature review
por: Xie, Tong, et al.
Publicado: (2021)

The utility of sputum supernatant as an alternative liquid biopsy specimen for next-generation sequencing-based somatic variation profiling
por: Qin, Ling, et al.
Publicado: (2022)

Characterizations of Cancer Gene Mutations in Chinese Metastatic Breast Cancer Patients
por: Tao, Zhonghua, et al.
Publicado: (2020)

A comparative analysis of the mutagenicity of platinum-containing chemotherapeutic agents reveals direct and indirect mutagenic mechanisms
por: Szikriszt, Bernadett, et al.
Publicado: (2021)

Discovery and validation of methylation signatures in blood-based circulating tumor cell-free DNA in early detection of colorectal carcinoma: a case–control study
por: Sui, Jinke, et al.
Publicado: (2021)

The prognostic value of longitudinal circulating tumor DNA profiling during osimertinib treatment
por: Ma, Shenglin, et al.
Publicado: (2021)

Open access-enabled evaluation of epigenetic age acceleration in colorectal cancer and development of a classifier with diagnostic potential
por: Widayati, Tyas Arum, et al.
Publicado: (2023)

Acquired multiple mutations ALK I1171N, L1196M and G1202R mediate lorlatinib resistance in EML4-ALK-rearranged malignant pleural mesothelioma: a case report
por: Hu, Jia, et al.
Publicado: (2020)

The association between BRAF mutation class and clinical features in BRAF-mutant Chinese non-small cell lung cancer patients
por: Lin, Quan, et al.
Publicado: (2019)

Differences in the clinicopathological characteristics of pure and mixed invasive micropapillary breast carcinomas from eastern China
por: Wang, Rong, et al.
Publicado: (2021)

A role for SETD2 loss in tumorigenesis through DNA methylation dysregulation
por: Javaid, Hira, et al.
Publicado: (2023)

H3K27me3 expression and methylation status in histological variants of malignant peripheral nerve sheath tumours
por: Lyskjær, Iben, et al.
Publicado: (2020)

The Relationship between Epigenetic Age and Myocardial Infarction/Acute Coronary Syndrome in a Population-Based Nested Case-Control Study
por: Malyutina, Sofia, et al.
Publicado: (2022)

Characterization of Frequently Mutated Cancer Genes and Tumor Mutation Burden in Chinese Breast Cancer
por: Xiao, Weikai, et al.
Publicado: (2021)

Mutational Landscape of PI3K-AKT-mTOR Pathway in Breast Cancer: Implications for Targeted Therapeutics
por: Xiao, Weikai, et al.
Publicado: (2021)

Comparative study on the mutational profile of adenocarcinoma and squamous cell carcinoma predominant histologic subtypes in Chinese non‐small cell lung cancer patients
por: Ding, Ying, et al.
Publicado: (2019)

Effects of andrographolide on postoperative cognitive dysfunction and the association with NF-κB/MAPK pathway
por: Ding, Yongbo, et al.
Publicado: (2017)

MYC amplifications are common events in childhood osteosarcoma
por: De Noon, Solange, et al.
Publicado: (2021)

Intraoperative use of dexmedetomidine promotes postoperative sleep and recovery following radical mastectomy under general anesthesia
por: Shi, Cunxian, et al.
Publicado: (2017)

Disease progression patterns and molecular resistance mechanisms to crizotinib of lung adenocarcinoma harboring ROS1 rearrangements
por: Zhang, Yongchang, et al.
Publicado: (2022)

GenomeChronicler: The Personal Genome Project UK Genomic Report Generator Pipeline
por: Guerra-Assunção, José Afonso, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hc6u3cp96fssngjqblsrlsektn